AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress RDZN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges YSS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as PreRevenue Stage Continues SCHW Q1 2026 Earnings Modest EPS Beat Amid Steady Performance VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income